Von Hippel Lindau disease: clinical and molecular perspectives

Keyphrases

• Von Hippel-Lindau Disease 100%
• Molecular Perspectives 100%
• Clinical Perspective 100%
• Tumor 20%
• Vascular Endothelial Growth Factor 20%
• Hypoxia-inducible factor-1α (HIF-1α) 20%
• Clear Cell Renal Cell Carcinoma (ccRCC) 20%
• Von Hippel-Lindau 20%
• Proteolysis 20%
• HIF-2 20%
• Hypoxia-inducible 20%
• Metabolism 10%
• Gene Products 10%
• Sporadic Tumors 10%
• Transcription Factor 10%
• Overexpressing 10%
• Protein Complex 10%
• Fibronectin 10%
• Clinical Management 10%
• Most Common Cause 10%
• Cell Cycle Regulation 10%
• Tumor Suppressor Gene 10%
• Specificity Protein 1 10%
• Germline mutation 10%
• Gene Inactivation 10%
• Variable Expression 10%
• Targeted Proteolysis 10%
• Hypervascular 10%
• Gene Carrier 10%
• Familial Cancer Syndrome 10%
• Multidisciplinary Approach 10%
• Patient Tumor 10%
• Von Hippel-Lindau Tumor Suppressor 10%
• Early Detection 10%
• Tissue-specific Function 10%
• Allelic Heterogeneity 10%
• Complex Genotypes 10%
• Multiple Organs 10%
• Ubiquitinylation 10%
• Tumorigenesis Mechanism 10%
• Malignant Neoplasms 10%
• F-box 10%
• CUL1 10%
• Sporadic Cancer 10%
• SKP1 10%
• Benign Neoplasm 10%
• Genotype-phenotype Correlation 10%
• Adaptor 10%
• Familial Cancer 10%

Biochemistry, Genetics and Molecular Biology

• Von Hippel-Lindau Disease 100%
• Proteolysis 42%
• Growth Factor 28%
• Transcription 14%
• Metabolic Pathway 14%
• Transcription Factors 14%
• Gene Inactivation 14%
• Carcinogenesis 14%
• Tumor Suppressor Gene 14%
• Gene Product 14%
• Germline Mutation 14%
• Skp1 14%
• Protein Complexes 14%
• Genotype Phenotype Correlation 14%
• Fibronectin 14%
• Von Hippel-Lindau Tumor Suppressor 14%
• Cell Cycle Regulation 14%